Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027 
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure 
US Dollar Slips as Markets Weigh Potential US-Iran Peace Deal and Oil Price Outlook 
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook 
Oil Prices Jump After New U.S. Strikes on Iran Raise Supply Concerns 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Nikkei Hits Record High as AI Chip Stocks Power Japan Market Rally 
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave 
ECB’s Philip Lane Warns Middle East Conflict Could Keep Inflation Elevated 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand 
Trump Administration Releases New UFO Files and Apollo Mission Records 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
